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1. Introduction 
Proteins are the most abundant molecules in biology which control virtually every 
biological process on which our lives depend. Therefore, understanding how newly 
synthesized proteins folds into the correct native structure and achieve their biologically 
functional states inside the cell is of paramount importance. Most of what is currently 
known about the process of protein folding has been studied by analyzing proteins outside 
the cells in a ‘dilute solution’ under in vitro conditions. The pioneering work on the creation 
of cell-free (in vitro) protein synthesis (CFPS) reported by Nirenberg and Matthaei in 1961 
has been a powerful and ever expanding tool for large-scale analysis of proteins [1]. In 
general, these systems are derived from the crude extract of cells engaged in a high rate of 
protein synthesis and are consist of all the macromolecular components required for 
translation of exogenous mRNA which are added separately in the system. The cell-free 
system offer several advantages over traditional cell-based (in vivo) systems which are 
specially not good at making exogenous proteins and those which are toxic to the host cell, 
undergoes rapid proteolytic degradation or forms inclusion bodies. Cell-free system 
provides the ability to easily manipulate the reaction components and conditions to favor 
protein synthesis, decreased sensitivity to product toxicity and suitability for 
miniaturization and high-throughput applications. With these advantages, there is 
continuous increasing interest in CFPS system among biotechnologists, molecular biologists 
and medical or pharmacologists. However, CFPS systems rely on the correct folding of the 
expressed polypeptide chain into a fully functional three-dimensional protein. Thus 
‘foldability’ of expressed protein in a cell-free system is one of the most challenging 
conundrums of CFPS science.  
The folding issue (misfolding or aggregation) is believed to be caused by excessive collision 
between growing peptide chain and with other macromolecular components of cell-free 
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system. It is estimated that the total concentration of macromolecules such as proteins, 
nucleic acids, ribosomes and carbohydrates in the crude cell extract is ranged from 300 to 
400 mg/mL that occupy about 30% of total cytoplasmic volume [2]. For easy understanding, 
if 30% of the volume of a cube is filled with macromolecules of a given size, uniformly 
distributed, then there is virtually no volume available for additional molecules of a similar 
size. This leads to ‘macromolecular crowding’ effect which can result in surprisingly large 
qualitative and quantitative effects on both the thermodynamic and kinetic of interactions 
among macromolecules. For example, it can favor the association of macromolecules which 
may lead to a dramatic acceleration in the rate of protein aggregation (a huge variety of 
diseases share the pathological feature of aggregated misfolded protein deposits such as 
formation of amyloid fibrils has a central role in the pathogenesis of Alzheimer disease) [3]. 
Second, crowding also limits the diffusion of molecules that limits the conformational 
flexibility of growing polypeptide chains, adding complexity to folding and multimerization 
reactions. Although CFPS is routinely carried out in relatively dilute solutions but yet the 
commonly used CFPS systems are estimated with a relatively crowding environments 
containing ~5% (w/v) of macromolecules [4]. Very recently, the inhibition of cell-free 
translation of Rluc mRNA was confirmed under macromolecular crowding conditions 
created by adding various biocompatible crowding agents. Interestingly, these crowding 
agents were observed to show an opposite effects on cell-free transcription reactions [4]. 
This study confirms that a macromolecule crowding may lead to terminal misfolding and 
therefore determine the folding rates. Thus protein folding which is crucial to the function of 
proteins requires controlled handling of translation reaction in CFPS system. In this stream, 
consideration of the protein behavior in their intracellular milieu is crucial. This chapter 
presents a novel approach, called solid-phase CFPS, which provides mimetic conditions of 
an intracellular milieu to facilitate efficient cell-free protein translation of more functionally 
active proteins. 
2. Co-translational protein folding: What we can learn? 
Protein synthesis is the universal mechanism for translating the genetic information into 
functional information in all kingdom of life and all synthesized proteins have in common 
to fold and express their biological activity. The machine which carries the protein synthesis 
is the ribosome, a large RNA-protein complex. However, the fundamental understanding of 
how does the ribosome move along an mRNA and how the linear amino acid sequence of a 
growing polypeptide chain folds correctly into its unique three-dimensional structure is still 
not completed. It is widely believed that protein folding generally begins during translation 
on the ribosome, called ‘co-translational folding’ [5-7]. This implies that the N-terminal part 
of a growing polypeptide starts its folding as soon as it has been synthesized, prior to the 
completion of entire polypeptide chain by the ribosome (see Fig.1). The experimental testing 
of this elegant idea was already begun in the early 1960s and today there is substantial 
experimental support for the co-translational folding hypothesis. Very recently, an efficient 
co-translational folding has been demonstrated by using an engineered multidomain fusion 
protein [8]. In one another study, the folding yield of fluorescent protein was compared 
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between ribosome-released GFP and chemically denatured GFP. The yield of native 
fluorescent GFP was dramatically higher with co-translational folding [9]. Although 
encouraging, but yet many details of co-translational folding pathway remain unanswered. 
For example, since the fact that the polypeptide synthesis requires many seconds (50-300 
residues/min) and the folding occurs in much less than one second (or microsecond-level), 
there must be formation of compact structures and/or intermediates in the process of protein 
synthesis. So, what types of structures are these and how they effects on the folding 
efficiency of newly synthesized protein is still remain elusive.  
 
Figure 1. A cartoon representation of ‘co-translational folding’ of a growing polypeptide chain on the 
ribosome. 
The ribosome serves as a platform for co-translational folding. A crucial process is the 
decision whether the folding occurs in the cytosol or across the membranes (eukaryotic 
endoplasmic reticulum (ER) membrane or bacterial plasma membrane). Eukaryotic co-
translational protein translocation involves the interaction of signal recognition particle 
(SRP) with ribosomes. The SRP recognize the hydrophobic signal sequence at the N termini 
of nascent peptide chains as they emerge from the exit tunnel of ribosome and then SRP-
RNC (ribosome–nascent chain) complex interacts with the ER membrane-bound SRP 
receptor to delivers nascent peptide chain to the ER membrane. This process slowing down 
chain elongation and lead to a transient arrest of translation. Once ribosome engages a 
proteinaceous channel located at the ER membrane, only then protein synthesis is resumed 
and nascent protein are co-translationally injected into the ER lumen. So, what we understand 
that slowing down the translation rate (as a result of co-translational process) may improve the 
folding efficiency of newly synthesized proteins. It has been observed that protein synthesis 
speed is faster in bacteria than in eukaryotes. In E. coli, polypeptide synthesis rates vary from 
10 to 20 amino acids per second [10] but it is considerably slower (3 to 8 amino acids per 
second) in the eukaryotes [11]. Presumably, this might be the reason why the eukaryotic 
cytosol appears to be highly capable of folding proteins efficiently (as a result of co-
translational folding) whereas folding of protein is delayed relative to their synthesis in the 
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bacterial cell. It is recently highlighted that a single codon mutation in mRNA that alters the 
translation rate can lead to a dramatic increase in the folding yield [12]. Thus, the speed of 
protein synthesis can affect protein folding pathways. And if this is true, then controlling the 
polypeptide synthesis rate would be promising step to improve the protein foldabiltiy in the 
CFPS systems. Since both the ribosomes and mRNA templates in the CFPS are not in a 
stationary mode (as they are in cell-based system represented by endoplasmic reticulum 
membrane-bound ribosome), providing a similar environment by introducing solid-phase 
chemistry would help to create co-translational protein folding in the CFPS systems. 
3. Solid-phase versus solution-phase chemistry for protein synthesis 
Solution dynamics (representing diversity of molecular conformations and motion) of 
biological macromolecules (e.g., DNAs, mRNAs) has been described by using nanosecond 
molecular dynamics or X-ray scattering approaches [13,14]. These studies suggest 
conformational variation including semi-stable or unstable structures having short life times 
is a general functional feature of these macromolecules and this is profoundly influenced by 
their environment, such as small changes in the concentration of solutes or salts can 
radically alter the properties of DNA/mRNA in the solution. These dynamics, such as spatial 
and temporal dynamic of mRNA movements that undergoes many conformational 
rearrangements and so an integral part of cell-based protein synthesis, however, may not 
require in the cell-free systems and thus should be avoided in the cell-free reactions. 
Secondly, exogenous mRNAs are extremely labile in nature and thus are apt to be degraded 
by contaminating nucleases that are inherently present in the crude cell extracts and thus the 
protein synthesis reaction is inhibited over time. Third, since CFPS carried out in relatively 
dilute concentrations, the ribosome turnover is likely less compared with the cell-based 
system. In order to exploit these issues, here we introduced solid-phase chemistry for the 
CFPS systems where the diffusional migration of key molecules (e.g., mRNAs or ribosomes) 
is restricted in a defined area to improve the positive reactions in a pseudo-first order 
fashion (see Fig.2).  
 
Figure 2. A schematic drawing of diffusional migration in solution-phase and solid-phase reactions. 
Blue circle represent the CFPS reactants. 
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Compared with solution-phase reaction, in which the reactants of CFPS are dispersed in a 
dilute solution, advantages of solid-phase CFPS reaction includes: (i) improved stability: 
the boundaries stabilized and protect biomolecules by capping the free terminal ends 
against nucleases degradation; (ii) higher local concentration: the local concentration of 
the reactants can be greatly increased in solid-phase, a condition that cannot be realized in 
the solution-phase because of the extra volume of the solvent and the fixed solubility of 
template DNAs/mRNAs. For example, ribosome-turnover can be increased to find its next 
substrate in solid-phase reaction; (iii) post-reaction steps: it become easier to perform 
purifications or remove excess reactant or byproducts from the reaction; (iv) co-
translational folding: it mimic the cell-bases system by introducing a diffusion barrier 
which significantly reduces the reaction rate and improve the co-translational folding. A 
schematic drawing of solid-phase CFPS is outlined in Fig.3 and compared with solution-
phase CFPS and cell-based system. Here, we should recall that protein synthesis is 
compartmentalized in the cell-based system and secretory/integral proteins being 
synthesized on endoplasmic reticulum (ER) by trafficking of the ribosome and mRNA 
from the cytoplasm to the ER membrane. Therefore, solid-phase CFPS where mRNAs are 
immobilized on a solid surface provides the similar environment with the cell-based 
system by controlling the reactions in a similar stationary mode using surface-bound 
mRNA, and this may help to direct protein folding. 
 
 
 
Figure 3. Schematic representation of protein synthesis in vivo (A) conventional in vitro solution-phase 
(B) and novel in vitro solid-phase (C). 
The solid-phase approach was first invented by Bruce Merrifield in 1963 in an effort to 
overcome difficulties inherent to the liquid-phase synthesis of peptide [15]. Later, the 
immobilization of biomolecule and synthetic solid-phase approaches have been successfully 
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aided research for a widespread applications for both pre-translated biomolecules such as 
RNA/DNA and post-translated biomolecules such as protein/enzymes including SNP 
genotyping [16], DNA amplification [17], differential display [18], in vitro transcription [19], 
immunoassay [20,21], and others while promoted the development of microfabrication 
[22,23], high-throughput screening and automation strategies in many areas including 
proteomics. Very recently, a hydrogel-based system was introduced that improved the 
efficiency of CFPS up to 300 times than solution phase-based system [24]. 
The simplest method for immobilization of biomolecules is physical adsorption between 
the molecule of interest, e.g., protein, and solid surface [25]. However a more stable and 
reliable mean of immobilization is a bonding or linkage between the molecule of interest 
and molecules of the solid support [26]. To date, several methods have been reported to 
bind the functional biomolecules with ligands onto glass, agarose bead gels and magnetic 
particles. Among these, the covalent nature bonding affinity has advantageous over non-
covalent bonding in the ability to orient the immobilized molecule in a defined and 
precise fashion for forthcoming reactions. The affinity of biotin for streptavidin is one of 
the strongest and most stable known in biochemistry [27]. Moreover, a wide range of 
immobilizing materials and binding modes allows a great deal of flexibility in order to 
design a specific bond with specific physical and chemical properties such as charge 
distribution, hydrophobic/hydrophilic, etc. In this chapter, we highlight our new 
approach of solid-phase protein synthesis to improve the stability and foldability of CFPS 
systems. 
4. General concepts for solid-phase CFPS 
In order to exploit the above issues, a novel solid-phase CFPS was described to produce 
proteins in their native folded-state which is schematically outlined in Fig. 4 [28].  The 
requires the template (mRNA) in a stationary phase, which is achieved by immobilizing the 
mRNA molecules to a solid-surface prior to translation. In order to perform solid-phase 
translation, the immobilization of mRNA must satisfy several requirements: (i) mRNAs 
should be attached efficiently to the solid surface via a 3’-UTR end linkage, (ii) the integrity 
of the mRNAs should not be affected by immobilization, (iii) the availability of the free 5’-
end of the mRNA must be sufficient for translation and (iv) the properties of the solid-
surface must be compatible with translation. These are achieved by coupling the mRNA of 
interest to a solid surface via ligation to a synthetic biotinylated DNA oligomer which is 
then immobilized to streptavidin-coated paramagnetic beads. An efficient ligation is an 
essential part of solid-phase translation and for this purpose we have engineered a synthetic 
linker-DNA molecule (see Fig. 4A). To perform an efficient ligation between the mRNA and 
linker-DNA molecules, the 3’-ends of the mRNAs are first hybridized to the linker-DNA 
and then incubated with T4 RNA ligase.  This reaction is efficient even at low concentrations 
of substrates as it is based on quasi-intramolecular ligation. In the next step of solid-phase 
translation, the bead-bounded mRNA molecules are incubated in a cell-free translation 
system (Fig. 4B). 
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Figure 4. Schematic representation of a novel solid-phase cell-free protein synthesis for synthesizing 
native and correctly folded protein.  
5. Yield of natively folded proteins by solid-phase CFPS 
To demonstrate the performance of solid-phase translation system, FP (fluorescent proteins: 
GFP, green fluorescent protein and mCherry) was chosen as the model proteins.  A T7 
promoter driven DNA template encoding mCherry with a stop codon was constructed and 
amplified with biotinylated primer. The PCR products were then immobilized onto 
streptavidin-coated paramagnetic beads. Following cell-free couple transcription/translation 
reaction, the beads were separated and the supernatant was analyzed by native SDS-PAGE.  
To compare the performances of solid-phase and solution-phase systems, an identical 
quantity of free PCR products without immobilization was processed in parallel. The 
original fluorescence of the folded mCherry protein was successfully resolved by SDS-PAGE 
as a major band of ~28 kDa (see Fig. 5A). The RFU (relative fluorescence units) values 
representing the foldability of mCherry bands were monitored by a fluorescence imager. 
The average results obtained by three successive experiments clearly show that synthesis of 
mCherry using novel solid-phase system was at above 2-fold of the solution-phase system 
(Fig. 5B).  
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Figure 5. Comparison of the protein synthesis of correctly folded mCherry by solid-phase and solution-
phase CFPS. A native SDS-PAGE analysis and quantitative measurements (B). 
Indeed, it was surprising to see that by simply converting the free DNA template to surface-
bounded template, the efficiency of protein synthesis using coupled transcription/ 
translation system was much improved. To understand this further, we studied the 
underlying mechanisms by investigating cell-free translation separately. For this purpose, a 
T7 promoter driven mRNA template encoding GFP with a stop codon and short stretch of 
complementary sequence of linker-DNA at the 3’-terminus was constructed (as shown 
partly in Fig.4A). This template was then ligated to linker-DNA and immobilized onto 
streptavidin-coated paramagnetic beads. Following cell-free translation in a wheat germ-
based system, the beads were separated and the supernatant was analyzed quantitatively by 
SDS-PAGE and qualitatively (i.e., correct folding) by a fluorescence microplate reader.  To 
compare the performances of solid-phase and solution-phase systems, an identical quantity 
of free mRNA-template without ligation or immobilization was processed in parallel.  To 
quantitatively compare the production between the solid- and solution-phase methods, GFP 
was expressed using fluorescently labeled lysine residues. Translated products were heated 
at 70°C for 5 min for complete denaturation and removal of the original fluorescence of the 
folded GFP protein, and resolved by SDS-PAGE. Heat-denatured (non-fluorescent) GFP 
migrates as a major band of about 27 kDa (Fig.6A, right two lanes). The intensity of 
FluoroTect labeled GFP bands were monitored by a fluorescence imager. The average 
results obtained by four successive experiments clearly show that production of GFP using 
our solid-phase system was at about 15% of the levels of the liquid-phase system (Fig.6B 
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inset, white columns). However, the quality analysis, i.e., foldability, of the GFP, for these 
two systems obtained by measuring the intensity of original green fluorescence, (Fig.6B 
inset, gray columns) showed similar results. The RFU (relative fluorescence units) values 
representing the foldability of GFP were directly measured using a fluorescence microplate 
reader, and for the solid-phase system was about 80% of the liquid-phase system. This 
suggests that although the production of GFP using the solid-phase approach is 
considerably less compared with the liquid-phase method, the proteins produced in the 
solid phase are up to four-fold more biologically active after normalization (Fig.6B). To 
confirm this finding, the solid-phase products were removed from the beads and then 
analyzed together with solution-phase products by SDS-PAGE.  The results showed a 37 
kDa GFP product from the solid phase reaction, which is shifted upwards from the 
denatured position predicted for its theoretical mass (27 kDa) due to its native folding 
(Fig.6A, left two lanes).  
 
Figure 6. Comparison of the correct folding and productivity of GFP produced by solid-phase and 
solution-phase CFPS systems. (A) SDS-PAGE of non-denatured (folded) GFP (leftmost two lanes) and 
denatured GFP (rightmost two lanes). (b) Quantitative measurements of the relative efficiency of Solid 
versus Solution-phase in terms of ratio values were plotted after recombining the productivity (white 
column) and foldability (grey column) performance (shown in inset) from the solution or solid-phase 
systems.  All plots and error bars represent average and standard coefficient values of more than four 
independent experiments. M, molecular weight markers. 
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6. Conclusion and future perspective 
This chapter described a novel solid-phase cell-free translation system in which template 
molecules (DNAs/mRNAs) were captured onto solid-surfaces to simultaneously induce co-
translational folding and synthesize proteins in a more native-state form. A newly 
constructed biotinylated linker-DNA is ligated to the 3’ ends of the mRNA molecules to 
attach the mRNA-template on a streptavidin-coated surface and further to enable the 
subsequent reactions of cell-free translation on surface. The protein products are therefore 
directly synthesized onto solid-surfaces and furthermore discovered to adopt a more native 
state with proper protein folding and enough biological activity compared with 
conventional solution-phase approaches. The approach described in this chapter may 
enables to embrace the concept of the transformation of ‘DNA-to-Protein microarrays’ using 
solid-phase cell-free protein synthesis system and thus to the development of high-
throughput, CFPS platform to the field of functional proteomics. 
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